MedPath

Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis

Completed
Conditions
Allergic Rhinoconjunctivitis
Registration Number
NCT02488447
Lead Sponsor
Roxall Medicina España S.A
Brief Summary

The purpose of ths study is to evaluate changes in life quality of patients affected by rhinoconjuntivitis with or without asthma after immunotherapy treatment. It is an observational, prospective and comparative study before-after immunotherapy treatment with a one year follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
215
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Life Quality as measured by RQLQ questionaire (≥12years)One Year
Secondary Outcome Measures
NameTimeMethod
Adherence as measured by patient diaryOne Year
Treatment Satisfaction as measured by visual analogue scaleOne Year

Trial Locations

Locations (14)

Complejp Hospitalario de Cáceres

🇪🇸

Cáceres, Extremadura, Spain

Complejo Hospitalario Universitario La Coruña

🇪🇸

La Coruña, Galicia, Spain

Hospital Central de la Cruz Roja

🇪🇸

Madrid, Spain

Hospital Fundación Jiménez Díaz

🇪🇸

Madrid, Spain

Hospital 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Universitario del Henares

🇪🇸

Madrid, Spain

Hospital del Tajo

🇪🇸

Madrid, Spain

Hospital del Norte Infanta Sofía

🇪🇸

Madrid, Spain

Hospital Universitario Fundación Alcorcón

🇪🇸

Madrid, Spain

Hospital universitario de Fuenlabrada

🇪🇸

Madrid, Spain

Centro Médico Alianza Médica

🇪🇸

Valladolid, Spain

Hospital Virgen de la Concha

🇪🇸

Zamora, Spain

Hospital Royo Vilanova

🇪🇸

Zaragoza, Spain

Hospital Universitario Lozano Blesa

🇪🇸

Zaragoza, Spain

© Copyright 2025. All Rights Reserved by MedPath